HAMILTON LANE ADVISORS LLC

Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2019		-0.06%	$0	0	-19,898	-100%		Q4 2019
30 Sep 2019	0.06%	0%	$147,000	19,898	0		$7.39	Q3 2019
30 Jun 2019	0.11%	0%	$223,000	19,898	0		$11.21	Q2 2019
31 Mar 2019	0.11%	-0.28%	$214,000	19,898	-48,855	-71%	$10.75	Q1 2019
31 Dec 2018	0.91%	-0.16%	$1,038,000	68,753	-12,000	-15%	$15.10	Q4 2018
30 Sep 2018	1.5%	0%	$1,000	80,753	0		$0.0124	Q3 2018
30 Jun 2018		0%	$2,000	80,753	0		$0.0248^*	Q2 2018
31 Mar 2018		0%	$3,000	105,533	0		$0.0284^*	Q1 2018
31 Dec 2017	0.55%	+0.24%	$1,064,000	50,394	+22,048	+78%	$21.11	Q4 2017
30 Sep 2017	0.35%	+0.35%	$515,000	28,346	+28,346	NEW	$18.17	Q3 2017
30 Jun 2017		-0.19%	$0	0	-21,199	-100%		Q2 2017
31 Mar 2017	0.19%	+0.19%	$366,000	21,199	+21,199	NEW	$17.26	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.